J&J (JNJ) Talks to Sell Hips-and-Knees Business for $20 Billion

Johnson & Johnson (JNJ) is in discussions to sell its hips-and-knees business to Apollo Global Management for approximately $20 billion. This potential divestiture is part of J&J's strategy to focus on core businesses and improve operational efficiency. If finalized, this deal could impact J&J's financial position and possibly affect its stock price. The move signals a significant shift in the company’s strategy, which is vital information for investors considering the financial health and direction of J&J.